bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on non-invasive diagnostics and early cancer detection, today announced initiation of the Company's planned ...
Implementation and evaluation of multi-cancer early detection testing at the Dana-Farber Cancer Institute: A retrospective analysis of clinical outcomes and diagnostic pathways. Real-world analysis of ...
(a) Deep learning-based circulating exosome analysis for lung cancer detection (copyright American Chemical Society, 2024); (b) The operational mechanism of the Förster resonance energy transfer (FRET ...
Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...
Lung cancer remains a leading cause of cancer-related mortality worldwide, highlighting the urgent need for a nuanced ...
NeXT Personal identifies circulating tumor DNA in 81% of early-stage lung adenocarcinoma cases, offering potential for better disease stratification and outcome prediction. Study: Ultrasensitive ctDNA ...
BEIJING, 4 February (BelTA - China Daily) - A Chinese research team has developed the world's first blood-based diagnostic kit that can tell whether lung nodules are benign or cancerous, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results